Lucence is a precision oncology company focused on bringing clarity to cancer care. With sensitive and non-invasive liquid biopsy tests, we provide doctors and their “cancer-fighters” life-changing information so that they can seek effective treatments.Our ultrasensitive liquid biopsy tests are based on proprietary AmpliMark™ sequencing technology and data analytics for earlier detection and effective treatment. Lucence is dual-headquartered in Singapore and California with CLIA-licensed, CAP-accredited laboratories in both locations.
Lucence is a precision oncology company focused on bringing clarity to cancer care. With sensitive and non-invasive liquid biopsy tests, we provide doctors and their “cancer-fighters” life-changing information so that they can seek effective treatments.Our ultrasensitive liquid biopsy tests are based on proprietary AmpliMark™ sequencing technology and data analytics for earlier detection and effective treatment. Lucence is dual-headquartered in Singapore and California with CLIA-licensed, CAP-accredited laboratories in both locations.
Lucence is a precision oncology company focused on bringing clarity to cancer care. With sensitive and non-invasive liquid biopsy tests, we provide doctors and their “cancer-fighters” life-changing information so that they can seek effective treatments.Our ultrasensitive liquid biopsy tests are based on proprietary AmpliMark™ sequencing technology and data analytics for earlier detection and effective treatment. Lucence is dual-headquartered in Singapore and California with CLIA-licensed, CAP-accredited laboratories in both locations.